(Q42467730)

1 November 2017

Breast cancer molecular profiling with single sample predictors: a retrospective analysis. (English)

1 reference

1 November 2017

1 reference

8

Jorge S Reis-Filho

1 reference

1 November 2017

1

Britta Weigelt

1 reference

1 November 2017

7

Alan Ashworth

1 reference

1 November 2017

4

Rachael Natrajan

1 reference

1 November 2017

6

Mitch Dowsett

1 reference

1 November 2017

David S P Tan

5

1 reference

ORCID Public Data File 2021

author name string

Alan Mackay

series ordinal

2

1 reference

PubMed ID

20181526

1 November 2017

Roger A'hern

series ordinal

3

1 reference

1 November 2017

22 February 2010

1 reference

Lancet Oncology Commission

1 November 2017

1 reference

1 November 2017

11

1 reference

1 November 2017

339-349

1 reference

1 November 2017

4

1 reference

Molecular portraits of human breast tumours

1 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970008-5

7 January 2021

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970008-5

7 January 2021

Repeated observation of breast tumor subtypes in independent gene expression data sets

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970008-5

7 January 2021

The molecular portraits of breast tumors are conserved across microarray platforms

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970008-5

7 January 2021

Supervised risk predictor of breast cancer based on intrinsic subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970008-5

7 January 2021

Introducing molecular subtyping of breast cancer into the clinic?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970008-5

7 January 2021

Effect of molecular disease subsets on disease-free survival in randomized adjuvant chemotherapy trials for estrogen receptor-positive breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970008-5

7 January 2021

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970008-5

7 January 2021

Subtypes of breast cancer show preferential site of relapse.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970008-5

7 January 2021

Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970008-5

7 January 2021

Breast cancer molecular subtypes respond differently to preoperative chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970008-5

7 January 2021

Molecular classification of breast cancer: limitations and potential

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970008-5

7 January 2021

Molecular subtypes in breast cancer evaluation and management: divide and conquer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970008-5

7 January 2021

A gene-expression signature as a predictor of survival in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970008-5

7 January 2021

Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970008-5

7 January 2021

Does chromosome 17 centromere copy number predict polysomy in breast cancer? A fluorescence in situ hybridization and microarray-based CGH analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970008-5

7 January 2021

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970008-5

7 January 2021

Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970008-5

7 January 2021

Concordance among gene-expression-based predictors for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970008-5

7 January 2021

A Coefficient of Agreement for Nominal Scales

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970008-5

7 January 2021

The Measurement of Observer Agreement for Categorical Data

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970008-5

7 January 2021

Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970008-5

7 January 2021

The effect of the stromal component of breast tumours on prediction of clinical outcome using gene expression microarray analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970008-5

7 January 2021

The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970008-5

7 January 2021

Breast cancer subtypes and response to docetaxel in node-positive breast cancer: use of an immunohistochemical definition in the BCIRG 001 trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970008-5

7 January 2021

Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970008-5

7 January 2021

Basal-like breast cancer: a critical review

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970008-5

7 January 2021

Do 'basal-like' breast cancers really exist?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970008-5

7 January 2021

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970008-5

7 January 2021

Repeatability of published microarray gene expression analyses

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970008-5

7 January 2021

Roadmap for developing and validating therapeutically relevant genomic classifiers

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970008-5

7 January 2021

Changes in differential gene expression because of warm ischemia time of radical prostatectomy specimens.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970008-5

7 January 2021

Gene-expression signatures in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970008-5

7 January 2021

Histological and molecular types of breast cancer: is there a unifying taxonomy?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970008-5

7 January 2021

Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970008-5

7 January 2021

Utilizing RNA interference to enhance cancer drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970008-5

7 January 2021

The breast cancer somatic 'muta-ome': tackling the complexity

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970008-5

7 January 2021

10.1016/S1470-2045(10)70008-5

Identifiers

DOI

1 reference

1 November 2017

1 reference

PubMed ID

20181526